| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |